Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KYNU | Q16719 | 1/20 | 0.44 |
| ▸ | SYK | P43405 | 1/20 | 0.44 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 3/20 | 0.41 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CTSB | P07858 | 2/20 | 0.41 |
| ▸ | CTSS | P25774 | 2/20 | 0.41 |
| ▸ | YAP1 | P46937 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27627317 | 1.00 | ALDH1A1 (0.45) | ALDH1A1ALOX15KYNUSYKKLK5 | |
| SCHEMBL19508750 | 0.84 | KLK5 (0.51) | KLK5CTSKCTSLCTSBCTSS | |
| SCHEMBL5358340 | 0.82 | MAPT (0.46) | SYKKLK5CTSKCTSLCTSB | |
| SCHEMBL8345705 | 0.82 | KLK5 (0.49) | KLK5CTSKCTSLCTSBCTSS | |
| SCHEMBL14523652 | 0.80 | CPB2 (0.41) | ALDH1A1SIRT2 | |
| SCHEMBL4256075 | 0.78 | KYNU (0.56) | ALDH1A1ALOX15KYNUSYKKLK5 | |
| SCHEMBL19694832 | 0.78 | KYNU (0.56) | ALDH1A1ALOX15KYNUSYKKLK5 | |
| SCHEMBL19694834 | 0.78 | KYNU (0.56) | ALDH1A1ALOX15KYNUSYKKLK5 | |
| SCHEMBL31035995 | 0.77 | TRHDE (0.52) | CTSLCTSBCTSSITGB3ITGA2B | |
| SCHEMBL13617435 | 0.77 | HDAC6 (0.46) | KLK5SIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8512675-B2 | N and/or Nα derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH2)3 (CO)3]+ by fac coordination | MALLINCKRODT LLC (US) | 2013-08-20 | — | — | US | disclosed |
| EP-1618380-B1 | N epsilon AND/OR N alpha DERIVATIZED, METAL AND ORGANIC PROTECTED L-HISTIDINE FOR COUPLING TO BIOMOLECULES FOR HIGHLY EFFICIENT LABELING WITH (M(OH2)3(CO)3)+ BY FAC COORDINATION | UNIV ZUERICH (CH) | 2009-12-30 | — | — | EP | disclosed |
| US-20070077195-A1 | \"N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination\ | UNIVERSITY OF ZURICH (CH) | 2007-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070077195-A1 | \"N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination\ | CPN1, NUCB2, NAA15 | ALDH1A1 2649/4885ALOX15 4014/4885KYNU 748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.